CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Invesco Currencyshares Canadian Dollar Trust  (FXC)
Other Ticker:  
 
    Sector  Financial    Industry Investment Services
   Industry Investment Services
   Sector  Financial
 
Price: $74.4400 $0.21 0.283%
Day's High: $74.46 Week Perf: 0.39 %
Day's Low: $ 74.28 30 Day Perf: 0.00
Volume (M): 17 52 Wk High: $ 78.74
Volume (M$): $ 1,295 52 Wk Avg: $75.53
Open: $74.36 52 Wk Low: $72.19



 Market Capitalization (Millions $) 156
 Shares Outstanding (Millions) 2
 Employees 1
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Invesco Currencyshares Canadian Dollar Trust

The CurrencyShares® Canadian Dollar Trust (the “Trust”) is a grantor trust that was formed on June 8, 2006. The Shares commenced trading on the New York Stock Exchange under the ticker symbol “FXC” on June 26, 2006. The primary listing of the Shares was transferred to NYSE Arca, Inc. (“NYSE Arca”) on October 30, 2007. The Trust issues shares (the “Shares”) in blocks of 50,000 (a “Basket”) in exchange for deposits of Canadian Dollars and distributes Canadian Dollars in connection with the redemption of Baskets.


The investment objective of the Trust is for the Shares to reflect the price in USD of Canadian Dollars plus accrued interest, if any, less the expenses of the Trust’s operations. The Shares are intended to offer investors an opportunity to participate in the market for the Canadian Dollar through an investment in securities. The Shares are intended to provide institutional and retail investors with a simple, cost-effective means of gaining investment benefits similar to those of holding the Canadian Dollar. The Shares are bought and sold on NYSE Arca like any other exchange-listed security. The Shares are backed by the assets of the Trust, which does not hold or use derivative products. The Trust is a passive investment vehicle and does not have any officers, directors or employees. The Trust does not engage in any activities designed to obtain profit from, or ameliorate losses caused by, changes in the price of the Canadian Dollar. Investing in the Shares does not insulate the investor from certain risks, including price volatility. The value of the holdings of the Trust is reported on the Trust’s website, www.currencyshares.com, each business day.



 

Invesco Currencyshares Canadian Dollar Trust's Segments
 
 
  Company Estimates  
  Revenue Outlook
Invesco Currencyshares Canadian Dollar Trust does not provide revenue guidance.

Earnings Outlook
Invesco Currencyshares Canadian Dollar Trust does not provide earnings estimates.

 
Geographic Revenue Dispersion

Nemaura Medical Inc.

Sales and Earnings Unchanged

In the third quarter Nemaura Medical Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Entegris Inc

Income Positive Again, Revenue up in Double Digits

Entegris Inc announced earnings per share of $0.57 and Sales of $398.60 millions in the forth quarter, Company's earnings turn positive per share, versus $-0.20 eps, earned in the same quarter a year ago, although Entegris Inc saw it's Sales rise by 14.57 % in the same period.

Cabot Microelectronics Corp

Income Positive Again, Sales very Strong

Cabot Microelectronics Corp announced earnings per share of $0.48 and Sales of $156.73 millions in the first quarter, Company's earnings turn positive per share, versus $-0.12 eps, earned in the same quarter a year ago, although Cabot Microelectronics Corp saw it's Sales rise by 58.44 % in the same period.

Motorcar Parts America Inc

Despite Surge in Sales Profitability not Reached

Motorcar Parts America Inc announced in the third quarter surge in Sales by 23.96 % to $124.11 millions from the same quarter a year ago, but it has lost money at $-0.16 per share.

Bionik Laboratories Corp.

Company Fail to Break-even Despite Surge in Sales

Bionik Laboratories Corp announced very strong Sales growth of 256.47 % year on year to $0.93 millions in the third quarter, but losses widen at $-0.91.






Customers Net Income grew by FXC's customers Net margin grew to
20.98 % 22.09 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
FXA        0.72% 
VIXY   -4.83%    
UDN   -0.24%    
FXSG   -0.08%    
FXS   -0.04%    
FXCH        0.28% 
• View Complete Report
   



     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STAG's Profile

Stock Price

STAG's Financials

Business Description

Fundamentals

Charts & Quotes

STAG's News

Suppliers

STAG's Competitors

Customers & Markets

Economic Indicators

STAG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071